000 01053nam a2200325 a 4500
005 20250914173459.0
008 080425s2008 gw a b 001 0 eng
020 _a9783527316991 (alk. paper)
020 _a352731699X (alk. paper)
039 9 _a200806021206
_bzainol
_y04-25-2008
_zratnab
040 _aukm
060 _aQV744
_b.B6152 2008
090 _aQV744.B6152 2008 9
245 0 0 _aBiosimulation in drug development /
_cedited by Martin Bertau, Erik Mosekilde, and Hans V. Westerhoff
260 _aWeinheim :
_bWiley-VCH,
_c2008
300 _axxviii, 512 p. :
_bill. (some col.) ;
_c25 cm.
650 2 _aDrug Design
650 2 _aComputer simulation
650 2 _aModels, Theoretical
700 1 _aBertau, Martin
700 1 _aMosekilde, Erik
700 1 _aWesterhoff, Hans V.
907 _a.b14181174
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV744.B6152 2008 9
914 _avtls003375858
990 _azr
991 _aJabatan Bioperubatan
998 _ad
_b2008-12-04
_cm
_da
_feng
_ggw
_y0
_z.b14181174
999 _c413634
_d413634